Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches ; day:3 ; month:5 ; year:2016 ; pages:1-5
Science China / Life sciences. Life sciences ; (3.5.2016), 1-5
- Urheber
-
Ding, Guoliang
- Beteiligte Personen und Organisationen
-
Chen, Hu
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-0017-3
- URN
-
urn:nbn:de:1111-20160505962
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ding, Guoliang
- Chen, Hu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Augmenting adoptive T cell therapy through universal chimeric costimulators
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Augmenting adoptive T cell therapy through universal chimeric costimulators
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Augmenting adoptive T cell therapy through universal chimeric costimulators
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma